Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause hair loss due to stress, with inflammation markers like D-dimer levels playing a role.

Transgender and gender diverse youth often have skin issues like acne and scarring, but few get referred to dermatologists.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Non-hospitalized COVID-19 patients often have lingering symptoms for at least 30 days.

The study has limitations, and future research should use better methods to improve treatment for children with hair loss.

People with androgenetic alopecia may have a higher risk of peripheral venous disorders.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Bariatric surgery helps with weight loss but can cause complications and nutritional deficiencies.

Strainful life events may significantly trigger alopecia areata.

Virtual healthcare significantly improves quality of life for men with hair loss if they stick to the treatment.

The letter suggests that the study's comparison group might have affected the results and calls for larger, more detailed future research.

The model accurately detects early-stage hair loss using images.

Repigmentation patterns in vitiligo depend on melanocyte source, lesion status, and therapy choice.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

The combination of spironolactone and low-dose minoxidil is generally safe for treating hair loss in adult females, with mostly mild side effects.

Dutasteride and finasteride do not increase mood disorder risk in men with hair loss.

PRAME helps distinguish between benign and malignant skin cells in most cases.

Stressful life events may trigger alopecia areata.

Finasteride and dutasteride are equally effective and safe for treating BPH.

Oral finasteride seems more effective for hair loss in postmenopausal women, but more research is needed.

Low-dose oral minoxidil combined with topical minoxidil improves hair density in breast cancer patients but may cause excess hair growth.

Taking medication for hair loss might cause sexual problems.